The latest skin cancer and melanoma news
Skin cancer doctors back Melanoma Institute call
Skin cancer GPs have backed a call by the Melanoma Institute of Australia at the…
Browsing: Melanoma and Skin Cancer
ESMO 2022: Highlights on neo-adjadjuvant vs adjuvant pembrolizumab in resected stage III-IV melanoma: SWOG S1801
ESMO 2022: Highlights on TILs versus ipilimumab in patients with advanced melanoma: The phase 3 study
Inhibiting key enzyme selectively kills melanoma cells, study shows
Researchers at Sanford Burnham Prebys, USA, led by Ze’ev Ronai, Ph.D., have shown for the…
ESMO 2022: Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma
“It’s not just what you give, it’s when you give it! SWOG S1801 demonstrates that…
Medical specialists urged not to undermine confidence in skin cancer treatment
The Skin Cancer College of Australia has expressed its disappointment with recent comments deriding skin…
EADV 2022: New major survey finds ‘healthy’ suntan myths persist despite warnings about skin cancer
8 in 10 Europeans believe tans are attractive with almost as many (73%) saying tans…
ESMO 2022: Cell therapy improves PFS in advanced melanoma, first phase 3 study shows
A novel treatment strategy with personalised cell therapy significantly improves progression-free survival compared to standard…
Identifying melanoma patients with high-risk disease
The use of additional adjuvant therapy beyond initial treatment has greatly improved outcomes and reduced…
Protein that detects light may play a role in the origin and progression of melanoma
Melanopsin (OPN4) is a light-sensing protein found in skin and retina cells. A new study…